China Resources Sanjiu Medical&Pharmaceutical Co.,Ltd.(000999),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

000999 China Resources Sanjiu Medical&Pharmaceutical Co.,Ltd.

Closing Auction 12-23 14:59:42

28.39

-0.12

-0.42%

High28.70	Low28.30	Vol7.81M
Open28.51	D1 Closing28.51	Amplitude1.40%
Mkt Cap47.24B	Tradable Cap47.21B	Total Shares1.66B
T/O222.00M	T/O Rate0.47%	Tradable Shares1.66B
P/B2.25	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"000999","market":"SZ","secType":"STK","nameCN":"China Resources Sanjiu Medical&Pharmaceutical Co.,Ltd.","latestPrice":28.39,"timestamp":1766473182000,"preClose":28.51,"halted":0,"volume":7814955,"delay":0,"changeRate":-0.0042,"floatShares":1663000000,"shares":1664000000,"eps":1.659,"marketStatus":"Closing Auction","change":-0.12,"latestTime":"12-23 14:59:42","open":28.51,"high":28.7,"low":28.3,"amount":222000000,"amplitude":0.014,"askPrice":28.41,"askSize":387,"bidPrice":28.41,"bidSize":387,"shortable":0,"etf":0,"ttmEps":1.659,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1766473200000},"marketStatusCode":4,"adr":0,"adjPreClose":28.51,"symbolType":"stock","openAndCloseTimeList":[[1766453400000,1766460600000],[1766466000000,1766473200000]],"highLimit":31.36,"lowLimit":25.66,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1664217858,"isCdr":false,"pbRate":2.25,"roa":"--","peRate":17.112719,"roe":"11.47%","epsLYR":2.63,"committee":-0.074163,"marketValue":47247000000,"turnoverRate":0.0047,"status":1,"floatMarketCap":47204000000},"requestUrl":"/m/hq/s/000999/tweets","defaultTab":"tweets","newsList":[{"id":"2590489399","title":"CR Sanjiu's Yiqi Qingfei Granules Placed on China's Medical Insurance List","url":"https://stock-news.laohu8.com/highlight/detail?id=2590489399","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590489399?lang=en_us&edition=fundamental","pubTime":"2025-12-09 11:53","pubTimestamp":1765252382,"startTime":"0","endTime":"0","summary":"China Resources Sanjiu Medical & Pharmaceutical's  Yiqi Qingfei Granules were included in China's National Reimbursement Drug List for Basic Medical Insurance, Maternity Insurance, and Work-Related Injury Insurance, according to a Hong Kong filing on Monday.The traditional Chinese medicine is used to strengthen the spleen, the pharmaceutical company said.The list is effective Jan. 1, 2026.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0012","BK0060","BK0188","BK0239","BK0010","BK0183","BK0196","BK0028","000999","BK0185","BK0175"],"gpt_icon":0},{"id":"1180420983","title":"China Resources Sanjiu (000999.SZ): Yiqi Qingfei Granules Included in National Reimbursement Drug List","url":"https://stock-news.laohu8.com/highlight/detail?id=1180420983","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180420983?lang=en_us&edition=fundamental","pubTime":"2025-12-08 16:50","pubTimestamp":1765183820,"startTime":"0","endTime":"0","summary":"China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999.SZ) announced that its product Yiqi Qingfei Granules has been included in the National Reimbursement Drug List (NRDL) for the first...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0183","BK0239","BK0185","BK0012","BK0175","BK0196","BK0028","BK0010","BK0060","000999","BK0188"],"gpt_icon":0},{"id":"1131023914","title":"Six Traditional Chinese Medicines Added to National Reimbursement Drug List, with Products from Kanion, Yiling, Sanjiu, and Fangsheng Included","url":"https://stock-news.laohu8.com/highlight/detail?id=1131023914","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131023914?lang=en_us&edition=fundamental","pubTime":"2025-12-08 11:50","pubTimestamp":1765165845,"startTime":"0","endTime":"0","summary":"At the 2025 High-Quality Development Conference for Innovative Drugs held yesterday, the updated National Reimbursement Drug List (NRDL) for Basic Medical Insurance, Maternity Insurance, and...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0046","BK0185","BK0097","000999","BK0010","BK0196","600557","002603","BK0175","BK0042","BK0183","BK0012","BK0028","BK0060","BK0239","BK0188","603998"],"gpt_icon":0},{"id":"1138777297","title":"High Goodwill and Subsidiary Performance Decline: China Resources Sanjiu's Post-Merger Growing Pains with Tasly","url":"https://stock-news.laohu8.com/highlight/detail?id=1138777297","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138777297?lang=en_us&edition=fundamental","pubTime":"2025-11-25 18:42","pubTimestamp":1764067341,"startTime":"0","endTime":"0","summary":"China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999.SZ) recently disclosed its Q3 2025 financial report, revealing a stark divergence between revenue and net profit. The company...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0196","BK0185","000999","BK0175","BK0183","BK0012","BK0060","BK0239","BK0028","BK0188","BK0010","600535"],"gpt_icon":0},{"id":"1160217558","title":"CSPC Pharma's HER2 Antibody Application Accepted, CR Sanjiu Secures Rare Disease Drug, Domestic CAR-T Goes Global for Over $860M","url":"https://stock-news.laohu8.com/highlight/detail?id=1160217558","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160217558?lang=en_us&edition=fundamental","pubTime":"2025-11-11 20:01","pubTimestamp":1762862481,"startTime":"0","endTime":"0","summary":"CSPC Pharma's Pertuzumab Application Accepted   On November 11, the CDE website showed that CSPC Pharma's pertuzumab injection application for HER2-positive breast cancer treatment was accepted....","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0185","LU0315179316.USD","159992","LU1008478684.HKD","LU0326950275.SGD","LU1226288253.USD","IE0008369823.USD","LU0140636845.USD","LU1152091754.HKD","06978","BK0060","LU1226288170.HKD","000999","LU1960683339.HKD","CAR","BK0196","LU1152091168.USD","LU1951186391.HKD","BK1515","IE00BZ08YS42.EUR","BK1574","BK0239","LU0072913022.USD","IE00B5MMRT66.SGD","BK1161","BK0175","LU1226287792.SGD","BK4230","LU1807302812.USD","LU1813983027.USD","01093","IE00B543WZ88.USD","IE00BZ08YR35.GBP","LU1226287529.USD","LU2039709279.SGD","BK0028","BK4022","LU0314109678.HKD","LU1328277881.USD","BK0012","LU0067412154.USD","BK1521","BK1191","BK0010","LU0501845795.SGD","BK0183","LU1226287875.USD","SG9999004220.SGD","IE00B031HY20.USD","LU0880133367.SGD","LU1993786604.SGD","HK0000165453.HKD","IE00BZ08YT58.USD","BK0188","IE0008368742.USD"],"gpt_icon":0},{"id":"2577592715","title":"BRIEF-China Resources Sanjiu Medical & Pharmaceutical Q3 Net Profit Down 4.3% Y/Y","url":"https://stock-news.laohu8.com/highlight/detail?id=2577592715","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577592715?lang=en_us&edition=fundamental","pubTime":"2025-10-24 18:33","pubTimestamp":1761301986,"startTime":"0","endTime":"0","summary":"BRIEF-China Resources Sanjiu Medical & Pharmaceutical Q3 Net Profit Down 4.3% Y/YOct 24  - China Resources Sanjiu Medical & Pharmaceutical Co Ltd 000999.SZ:SAYS Q3 NET PROFIT DOWN 4.3% Y/YSource textFurther company coverage: 000999.SZ  ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251024:nL4N3W50VH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0175","BK0196","BK0185","BK0012","BK0188","000999","BK0028","BK0060","BK0183","BK0010","BK0239"],"gpt_icon":0},{"id":"1176258124","title":"China Resources Sanjiu Faces Growth Bottleneck: Revenue Up But Profits Down as CHC Business Revenue Falls 18%, Acquisition Aftereffects Emerge with Massive Goodwill Overhead","url":"https://stock-news.laohu8.com/highlight/detail?id=1176258124","media":"Deep News","labels":["dataReport","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176258124?lang=en_us&edition=fundamental","pubTime":"2025-09-18 18:50","pubTimestamp":1758192649,"startTime":"0","endTime":"0","summary":"Recently, China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. released its 2025 interim report. The data shows that the company achieved operating revenue of 14.81 billion yuan, a year-on-year...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0188","BK0239","BK0185","000999","BK0060","BK0175","BK0183","BK0012","166401","BK0010","BK0028","BK0196"],"gpt_icon":0},{"id":"2568441663","title":"CR Sanjiu to Invest 10 Billion Yuan in Bank Wealth Management Products","url":"https://stock-news.laohu8.com/highlight/detail?id=2568441663","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568441663?lang=en_us&edition=fundamental","pubTime":"2025-09-18 09:33","pubTimestamp":1758159189,"startTime":"0","endTime":"0","summary":"China Resources Sanjiu Medical & Pharmaceutical  will invest up to 10 billion yuan in bank wealth management products and structured deposits.The funds will be placed in fixed-income, low- to medium-risk products with terms of up to six months, according to a Thursday filing with the Shenzhen bourse.The plan runs from shareholder approval until October 2026.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0012","BK0239","BK0185","BK0028","BK0196","BK0188","000999","BK0010","BK0183","BK0175","BK0060"],"gpt_icon":0},{"id":"2568020460","title":"China Resources Sanjiu Medical & Pharmaceutical  Says Co Plans to Invest up to 10 Bln Yuan in Wealth Management Products","url":"https://stock-news.laohu8.com/highlight/detail?id=2568020460","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568020460?lang=en_us&edition=fundamental","pubTime":"2025-09-17 19:02","pubTimestamp":1758106969,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250917:nL3N3V40PL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK0012","BK0239","BK0185","BK0028","BK0196","BK0188","000999","BK0010","BK0183","BK0175","BK0060"],"gpt_icon":0},{"id":"1130527698","title":"Over 7 Billion Yuan in Goodwill Looms Large as China Resources Sanjiu's \"M&A Prescription\" Fails to Cure Growth Woes","url":"https://stock-news.laohu8.com/highlight/detail?id=1130527698","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130527698?lang=en_us&edition=fundamental","pubTime":"2025-08-22 16:51","pubTimestamp":1755852701,"startTime":"0","endTime":"0","summary":"China Resources Sanjiu Medical & Pharmaceutical Co.,Ltd.'s latest semi-annual report reveals a glaring wound: while revenue grew modestly by 4.99% to 14.81 billion yuan, net profit plummeted 24.31%...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0183","BK0185","BK0175","BK0060","BK0188","BK0010","BK0196","000999","BK0239","BK0012","BK0028"],"gpt_icon":0},{"id":"2560290318","title":"Jefferies Adjusts China Resources Sanjiu Medical & Pharmaceutical's Price Target to 25 Yuan From 27.70 Yuan, Keeps at Underperform","url":"https://stock-news.laohu8.com/highlight/detail?id=2560290318","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560290318?lang=en_us&edition=fundamental","pubTime":"2025-08-18 17:54","pubTimestamp":1755510860,"startTime":"0","endTime":"0","summary":"China Resources Sanjiu Medical & Pharmaceutical (SHE:000999) has an average rating of overweight and mean price target of 40.67 yuan, according to analysts polled by FactSet.(MT Newswires covers equit","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["000999"],"gpt_icon":0},{"id":"2560975712","title":"CR Sanjiu Medical & Pharmaceutical's Attributable Profit Slides 24%; Shares Fall 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2560975712","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560975712?lang=en_us&edition=fundamental","pubTime":"2025-08-18 10:30","pubTimestamp":1755484227,"startTime":"0","endTime":"0","summary":"China Resources Sanjiu Medical & Pharmaceutical's  attributable profit fell 24% to 1.82 billion yuan in the first half from 2.40 billion yuan in the year-ago period, according to a Saturday filing with the Shenzhen bourse.Shares fell 3% during morning trading on Monday.Earnings per share at the drug company reached 1.09 yuan, missing a Visible Alpha estimate of 1.39 yuan, and declining 24% from 1.44 yuan in the prior-year period.Revenue reached 14.8 billion yuan, matching Visible Alpha estimates and rising 5% from 14.1 billion yuan in the year-ago period.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0188","000999","BK0185","BK0028","BK0239","BK0010","BK0175","BK0012","BK0060","BK0196","BK0183"],"gpt_icon":0},{"id":"1133259000","title":"China Resources Sanjiu Faces Profit Decline Over 20% in H1 Due to Health Consumer Products Business Slowdown and Acquisition Integration Challenges","url":"https://stock-news.laohu8.com/highlight/detail?id=1133259000","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133259000?lang=en_us&edition=fundamental","pubTime":"2025-08-17 22:21","pubTimestamp":1755440471,"startTime":"0","endTime":"0","summary":"China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. encountered a \"revenue growth without profit growth\" dilemma in its first performance test following the acquisition. On August 15, China...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["000999","BK0060","BK0185","BK0175","BK0196","BK0239","BK0183","BK0012","BK0028","BK0188","BK0010"],"gpt_icon":0},{"id":"1132205675","title":"China Resources Sanjiu's Qiu Huawei: Focusing on Silver Economy Blue Ocean and New Quality Productive Forces to Cultivate Future Industries","url":"https://stock-news.laohu8.com/highlight/detail?id=1132205675","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132205675?lang=en_us&edition=fundamental","pubTime":"2025-08-17 10:51","pubTimestamp":1755399074,"startTime":"0","endTime":"0","summary":"The 18th Health Industry (International) Ecosystem Conference was held from August 16 to 21 in Boao, Hainan. Qiu Huawei, Chairman of China Resources Sanjiu Medical & Pharmaceutical Co.,Ltd.,...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0175","BK0196","BK0185","BK0012","BK0188","000999","BK0028","BK0060","BK0183","BK0010","BK0239"],"gpt_icon":0},{"id":"1160538642","title":"How to Navigate Cycles? China Resources Sanjiu's Qiu Huawei: Reshape Rules, Make Compliance the Wings","url":"https://stock-news.laohu8.com/highlight/detail?id=1160538642","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160538642?lang=en_us&edition=fundamental","pubTime":"2025-08-17 10:00","pubTimestamp":1755396037,"startTime":"0","endTime":"0","summary":"The 18th Health Industry (International) Ecological Conference was held in Boao, Hainan from August 16 to 21. At the opening ceremony, Qiu Huawei, Chairman of China Resources Sanjiu Medical &...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0175","BK0185","BK0196","BK0028","BK0183","BK0188","BK0060","BK0012","BK0010","000999","BK0239"],"gpt_icon":0},{"id":"2559169249","title":"BRIEF-China Resources Sanjiu Medical & Pharmaceutical H1 Net Profit Down 24.3% Y/Y","url":"https://stock-news.laohu8.com/highlight/detail?id=2559169249","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559169249?lang=en_us&edition=fundamental","pubTime":"2025-08-15 18:44","pubTimestamp":1755254651,"startTime":"0","endTime":"0","summary":"BRIEF-China Resources Sanjiu Medical & Pharmaceutical H1 Net Profit Down 24.3% Y/YAug 15  - China Resources Sanjiu Medical & Pharmaceutical Co Ltd 000999.SZ:H1 NET PROFIT DOWN 24.3% Y/YSource textFurther company coverage: 000999.SZ  ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250815:nL4N3U70O5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0188","000999","BK0185","BK0028","BK0239","BK0010","BK0175","BK0012","BK0060","BK0196","BK0183"],"gpt_icon":0},{"id":"1100421063","title":"Board Secretary Salary Comparison Among Listed Chinese Medicine Companies: China Resources Sanjiu Medical&Pharmaceutical Co.,Ltd.'s Xing Jian Tops Industry with 2.5587 Million Yuan Annual Salary Despite Less Than One Year in Position","url":"https://stock-news.laohu8.com/highlight/detail?id=1100421063","media":"Deep News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100421063?lang=en_us&edition=fundamental","pubTime":"2025-08-01 15:18","pubTimestamp":1754032701,"startTime":"0","endTime":"0","summary":"Board secretaries serve as crucial \"bridges\" connecting investors with listed companies and play key roles in corporate capital operations. The 2024 A-Share Board Secretary Data Report reveals that...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0060","BK0185","000999","BK0188","BK0183","PK","BK4218","BK0028","BK0239","BK4181","BK0175","BK0012","BK0010","BK0196"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2000-03-09","address":"广东省深圳市龙华区观湖街道观澜高新园区观清路1号","stockEarnings":[{"period":"1week","weight":0.0064},{"period":"1month","weight":0.0046},{"period":"3month","weight":0.0309},{"period":"6month","weight":-0.0879},{"period":"1year","weight":-0.1826},{"period":"ytd","weight":-0.1447}],"companyName":"华润三九医药股份有限公司","boardCode":"AI0027","perCapita":"17069股","boardName":"医药制造业","registeredCapital":"166421万元","compareEarnings":[{"period":"1week","weight":0.0128},{"period":"1month","weight":0.0215},{"period":"3month","weight":0.025},{"period":"6month","weight":0.1335},{"period":"1year","weight":0.1631},{"period":"ytd","weight":0.1687}],"survey":"　　华润三九医药股份有限公司的主营业务是高质量医药健康产品创新研发和智能制造。公司的主要产品是CHC健康消费品、处方药。华润三九已连续多年位列中国非处方药协会发布的非处方药生产企业综合排名榜首，连续两年位列“中国医药工业中药企业百强榜单”第二名。公司跻身2024凯度BrandZ最具价值中国品牌100强，跃居益普索《2025中国品牌影响力指数(BII)》第29 位。“999”主品牌在消费者和医药行业中均享有较高的认可度，多次被评为“中国最高认知率商标”“中国最有价值品牌”，是医药行业中首个荣获“中央企业品牌引领行动首批优秀成果产品品牌”的品牌。公司已连续3年获评国务院国资委“科改行动”最高评级“标杆”荣誉。","serverTime":1766473183241,"listedPrice":8.45,"stockholders":"97407人(较上一季度增加0.28%)","compareStock":{"symbol":"000001.SH","name":"SSE Comp"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"China Resources Sanjiu Medical&Pharmaceutical Co.,Ltd.(000999),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest China Resources Sanjiu Medical&Pharmaceutical Co.,Ltd.(000999) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"China Resources Sanjiu Medical&Pharmaceutical Co.,Ltd.,000999,China Resources Sanjiu Medical&Pharmaceutical Co.,Ltd.股票,China Resources Sanjiu Medical&Pharmaceutical Co.,Ltd.股票老虎,China Resources Sanjiu Medical&Pharmaceutical Co.,Ltd.股票老虎国际,China Resources Sanjiu Medical&Pharmaceutical Co.,Ltd.行情,China Resources Sanjiu Medical&Pharmaceutical Co.,Ltd.股票行情,China Resources Sanjiu Medical&Pharmaceutical Co.,Ltd.股价,China Resources Sanjiu Medical&Pharmaceutical Co.,Ltd.股市,China Resources Sanjiu Medical&Pharmaceutical Co.,Ltd.股票价格,China Resources Sanjiu Medical&Pharmaceutical Co.,Ltd.股票交易,China Resources Sanjiu Medical&Pharmaceutical Co.,Ltd.股票购买,China Resources Sanjiu Medical&Pharmaceutical Co.,Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"China Resources Sanjiu Medical&Pharmaceutical Co.,Ltd.(000999),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest China Resources Sanjiu Medical&Pharmaceutical Co.,Ltd.(000999) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction